Swiss pharmaceutical giant Novartis, a current and former subsidiary, has agreed to pay a total of $346.7m to reach settlements with the US Department of Justice (DOJ) and Securities and Exchange Commission (SEC) following investigations into bribery schemes.
The DOJ …
Read More